^
Association details:
| Biomarker: | LDH elevation |
|---|---|
| Cancer: | HER2 Positive Breast Cancer |
| Drug: | Herceptin (trastuzumab) (HER2 inhibitor) |
| Direction: | Resistant |
Evidence:
Source:
Title:
Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast Cancer Treated With Trastuzumab
Published date:
10/29/2019
Excerpt:
...higher LDH was associated with inferior progression-free survival (PFS) (P = 0.045) and OS (P = 0.010).
DOI:
10.2147/DDDT.S212610
